Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)

SHE:300009 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	327.47	299.18	260.23	324.59	322.56	248.07
Short-Term Investments	139.05	-	-	-	-	-
Trading Asset Securities	749	1,145	1,196	842.91	805.43	646.45
Cash & Short-Term Investments	1,216	1,444	1,456	1,167	1,128	894.52
Cash Growth	4.64%	-0.82%	24.70%	3.50%	26.10%	26.86%
Accounts Receivable	521.28	492.35	597.44	476.3	543.89	475.6
Other Receivables	32.88	30.54	9	11.25	46.96	96.36
Receivables	554.15	522.9	606.44	487.55	590.85	571.96
Inventory	284.31	297.3	235.22	210.48	181.25	155.12
Other Current Assets	26.69	11.03	28.03	45.02	21.53	19.75
Total Current Assets	2,081	2,275	2,325	1,911	1,922	1,641
Property, Plant & Equipment	1,585	1,584	1,434	1,176	881.34	766.66
Long-Term Investments	504.26	515.54	404.38	347.89	188.09	163.14
Goodwill	66.56	66.56	66.56	57.6	57.6	380.2
Other Intangible Assets	407.76	412.32	450.36	275.64	126.22	119.34
Long-Term Deferred Tax Assets	44.14	41.8	29.53	41.8	51.22	39.65
Long-Term Deferred Charges	211.64	223.28	223.8	413.28	386.18	367.14
Other Long-Term Assets	22.51	17.15	17.1	34.41	56.81	27.39
Total Assets	4,923	5,135	4,951	4,257	3,669	3,505
Accounts Payable	204.31	215.02	211.7	151.01	141.11	69.88
Accrued Expenses	206.4	238.6	328.25	240.6	306.76	200.45
Short-Term Debt	7	5	-	3	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	14.01
Current Portion of Leases	9.33	10.71	8.81	6.08	3.3	-
Current Income Taxes Payable	42.94	58.22	43.91	46.88	93.12	71.02
Current Unearned Revenue	18.94	19.34	24.43	27.96	19.51	13.43
Other Current Liabilities	130.48	120.69	229.98	200.27	62.99	103.75
Total Current Liabilities	619.41	667.59	847.08	675.8	626.79	472.54
Long-Term Leases	31.5	38.25	47.82	24.06	23.74	-
Long-Term Unearned Revenue	120.28	121.53	113.52	114.16	107.18	94.68
Long-Term Deferred Tax Liabilities	8.05	8.05	10.01	41.14	7.81	9.07
Total Liabilities	779.24	835.41	1,018	855.17	765.52	576.29
Common Stock	1,673	1,673	1,677	1,673	1,638	1,365
Additional Paid-In Capital	463.85	508.66	519.82	405.73	186.87	442.64
Retained Earnings	2,007	2,058	1,767	1,337	961.26	1,028
Treasury Stock	-102.04	-114.57	-226.22	-207.41	-	-
Total Common Equity	3,970	4,124	3,737	3,209	2,787	2,836
Minority Interest	173.29	175.63	194.93	193.09	116.97	92.85
Shareholders' Equity	4,144	4,300	3,932	3,402	2,904	2,929
Total Liabilities & Equity	4,923	5,135	4,951	4,257	3,669	3,505
Total Debt	47.83	53.96	56.63	33.14	27.04	14.01
Net Cash (Debt)	1,168	1,390	1,399	1,134	1,101	880.5
Net Cash Growth	5.83%	-0.66%	23.35%	3.03%	25.04%	30.04%
Net Cash Per Share	0.70	0.83	0.84	0.69	0.69	0.54
Filing Date Shares Outstanding	1,674	1,641	1,661	1,589	1,638	1,638
Total Common Shares Outstanding	1,674	1,641	1,661	1,589	1,638	1,638
Working Capital	1,461	1,608	1,478	1,235	1,295	1,169
Book Value Per Share	2.37	2.51	2.25	2.02	1.70	1.73
Tangible Book Value	3,496	3,645	3,220	2,875	2,603	2,336
Tangible Book Value Per Share	2.09	2.22	1.94	1.81	1.59	1.43
Buildings	584.11	582.74	583.06	564.87	469.79	428.33
Machinery	726.75	722.81	624.66	562.37	528.17	513.09
Construction In Progress	838.87	799.75	672.51	445.68	228.75	136.79

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.